Neumora Therapeutics Inc.... (NMRA)
NASDAQ: NMRA
· Real-Time Price · USD
1.62
0.04 (2.53%)
At close: Aug 15, 2025, 3:59 PM
1.66
2.47%
After-hours: Aug 15, 2025, 07:51 PM EDT
Neumora Therapeutics Common Stock Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 318K | n/a | 160K | 158K | 166K | 1.02M | 991K | 957K | 927K | 922K | 479K | 369K | n/a | n/a | n/a | 315K |
Gross Profit | n/a | n/a | n/a | n/a | -160K | -158K | -166K | -1.02M | -991K | -957K | -927K | -922K | -479K | -369K | n/a | n/a | n/a | -315K |
Operating Income | -54.04M | -70.94M | -62.92M | -76.65M | -63.82M | -60.07M | -114M | -56.86M | -42.06M | -39.17M | -30.72M | -30.6M | -31.31M | -43.24M | -26.55M | -178.13M | -17.2M | -15.45M |
Interest Income | n/a | 3.07M | 4.09M | 4.21M | 5.27M | 6.37M | 5.65M | 3.84M | 3.56M | 3.57M | 2.29M | 1.41M | 784K | 86K | n/a | n/a | n/a | n/a |
Pretax Income | -52.71M | -67.89M | -58.82M | -72.49M | -58.58M | -53.72M | -108.46M | -53.03M | -38.54M | -35.63M | -28.15M | -29.34M | -30.37M | -43.04M | -26.97M | -178.03M | -17.01M | -15.3M |
Net Income | -52.73M | -67.99M | -58.82M | -72.55M | -58.7M | -53.72M | -108.73M | -53.03M | -38.54M | -35.63M | -28.15M | -29.34M | -30.37M | -43.04M | -26.97M | -178.03M | -17.01M | -15.3M |
Selling & General & Admin | 15.32M | 18.79M | 17.01M | 16.02M | 15.19M | 14.32M | 11.24M | 15.26M | 9.29M | 9.68M | 7.2M | 8.05M | 7.79M | 8.09M | 7.64M | 6.66M | 6.31M | 3.94M |
Research & Development | 38.72M | 52.15M | 45.91M | 60.63M | 48.63M | 45.76M | 102.77M | 41.6M | 32.77M | 29.48M | 23.52M | 22.55M | 23.53M | 35.15M | 18.91M | 171.47M | 10.89M | 11.5M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -12K | -104K | -1K | -39K | -26K | 287K | -148K | 158K | 108K | n/a | 103K | n/a | 141K |
Operating Expenses | 54.04M | 70.94M | 62.92M | 76.65M | 63.82M | 60.07M | 114M | 56.86M | 42.06M | 39.17M | 30.72M | 30.6M | 31.31M | 43.24M | 26.55M | 178.13M | 17.2M | 15.45M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 70.94M | 63.24M | 76.65M | 63.82M | 60.07M | 114M | 56.86M | 42.06M | 39.17M | 30.72M | 30.6M | 31.31M | 43.24M | 26.55M | 178.13M | 17.2M | 15.45M |
Income Tax Expense | 25K | 105K | n/a | 53K | 125K | n/a | -5.38M | n/a | n/a | n/a | n/a | n/a | n/a | -86K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 161.69M | 161.45M | 160.98M | 159.58M | 158.98M | 157.94M | 158.83M | 155.39M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M |
Shares Outstanding (Diluted) | 161.69M | 161.45M | 160.98M | 159.58M | 158.98M | 157.94M | 158.83M | 155.39M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M |
EPS (Basic) | -0.33 | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 | -0.68 | -0.34 | -0.25 | -0.23 | -0.19 | -0.19 | -0.2 | -0.28 | -0.18 | -1.17 | -0.11 | -0.1 |
EPS (Diluted) | -0.33 | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 | -0.68 | -0.34 | -0.25 | -0.23 | -0.19 | -0.19 | -0.2 | -0.28 | -0.18 | -1.17 | -0.11 | -0.1 |
EBITDA | -54.04M | -70.94M | -62.77M | -76.49M | -63.66M | -59.92M | -100.3M | -55.84M | -41.07M | -38.21M | -29.79M | -29.68M | -30.84M | -43.09M | -26.42M | -177.98M | -17.07M | -15.13M |
EBIT | -54.04M | -70.94M | -62.92M | -76.65M | -63.82M | -60.07M | -114M | -56.86M | -42.06M | -39.17M | -30.72M | -30.6M | -31.31M | -43.24M | -26.55M | -178.13M | -17.2M | -15.45M |
Depreciation & Amortization | n/a | 157K | 157K | 156K | 160K | 158K | 166K | 1.02M | 991K | 957K | 927K | 922K | 479K | 369K | 131K | 150K | 125K | 315K |